BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 22822074)

  • 41. Stochastic properties of processive cytidine DNA deaminases AID and APOBEC3G.
    Chelico L; Pham P; Goodman MF
    Philos Trans R Soc Lond B Biol Sci; 2009 Mar; 364(1517):583-93. PubMed ID: 19022738
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Advances in the study of molecular mechanism of APOBEC3G anti-HIV-1].
    Fan B; Cen S; Jiang JD
    Yao Xue Xue Bao; 2008 Jul; 43(7):678-82. PubMed ID: 18819469
    [TBL] [Abstract][Full Text] [Related]  

  • 43. APOBEC3G & HTLV-1: inhibition without deamination.
    Strebel K
    Retrovirology; 2005 May; 2():37. PubMed ID: 15921532
    [TBL] [Abstract][Full Text] [Related]  

  • 44. APOBEC3A and APOBEC3B Preferentially Deaminate the Lagging Strand Template during DNA Replication.
    Hoopes JI; Cortez LM; Mertz TM; Malc EP; Mieczkowski PA; Roberts SA
    Cell Rep; 2016 Feb; 14(6):1273-1282. PubMed ID: 26832400
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA.
    Zhang H; Yang B; Pomerantz RJ; Zhang C; Arunachalam SC; Gao L
    Nature; 2003 Jul; 424(6944):94-8. PubMed ID: 12808465
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Visualization of uracils created by APOBEC3A using UdgX shows colocalization with RPA at stalled replication forks.
    Stewart JA; Schauer G; Bhagwat AS
    Nucleic Acids Res; 2020 Nov; 48(20):e118. PubMed ID: 33074285
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The retroviral hypermutation specificity of APOBEC3F and APOBEC3G is governed by the C-terminal DNA cytosine deaminase domain.
    Haché G; Liddament MT; Harris RS
    J Biol Chem; 2005 Mar; 280(12):10920-4. PubMed ID: 15647250
    [TBL] [Abstract][Full Text] [Related]  

  • 48. HMCES Maintains Replication Fork Progression and Prevents Double-Strand Breaks in Response to APOBEC Deamination and Abasic Site Formation.
    Mehta KPM; Lovejoy CA; Zhao R; Heintzman DR; Cortez D
    Cell Rep; 2020 Jun; 31(9):107705. PubMed ID: 32492421
    [TBL] [Abstract][Full Text] [Related]  

  • 49. DNA mutagenic activity and capacity for HIV-1 restriction of the cytidine deaminase APOBEC3G depend on whether DNA or RNA binds to tyrosine 315.
    Polevoda B; Joseph R; Friedman AE; Bennett RP; Greiner R; De Zoysa T; Stewart RA; Smith HC
    J Biol Chem; 2017 May; 292(21):8642-8656. PubMed ID: 28381554
    [TBL] [Abstract][Full Text] [Related]  

  • 50. APOBEC3G DNA deaminase acts processively 3' --> 5' on single-stranded DNA.
    Chelico L; Pham P; Calabrese P; Goodman MF
    Nat Struct Mol Biol; 2006 May; 13(5):392-9. PubMed ID: 16622407
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Strand-biased cytosine deamination at the replication fork causes cytosine to thymine mutations in Escherichia coli.
    Bhagwat AS; Hao W; Townes JP; Lee H; Tang H; Foster PL
    Proc Natl Acad Sci U S A; 2016 Feb; 113(8):2176-81. PubMed ID: 26839411
    [TBL] [Abstract][Full Text] [Related]  

  • 52. HIV-1 Vif versus APOBEC3G: newly appreciated warriors in the ancient battle between virus and host.
    Argyris EG; Pomerantz RJ
    Trends Microbiol; 2004 Apr; 12(4):145-8. PubMed ID: 15116720
    [No Abstract]   [Full Text] [Related]  

  • 53. APOBEC3 Host Restriction Factors of HIV-1 Can Change the Template Switching Frequency of Reverse Transcriptase.
    Adolph MB; Ara A; Chelico L
    J Mol Biol; 2019 Mar; 431(7):1339-1352. PubMed ID: 30797859
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Heat shock protein 70 inhibits HIV-1 Vif-mediated ubiquitination and degradation of APOBEC3G.
    Sugiyama R; Nishitsuji H; Furukawa A; Katahira M; Habu Y; Takeuchi H; Ryo A; Takaku H
    J Biol Chem; 2011 Mar; 286(12):10051-7. PubMed ID: 21228271
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Phosphorylation directly regulates the intrinsic DNA cytidine deaminase activity of activation-induced deaminase and APOBEC3G protein.
    Demorest ZL; Li M; Harris RS
    J Biol Chem; 2011 Jul; 286(30):26568-75. PubMed ID: 21659520
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Suppression of HIV-1 infection by APOBEC3 proteins in primary human CD4(+) T cells is associated with inhibition of processive reverse transcription as well as excessive cytidine deamination.
    Gillick K; Pollpeter D; Phalora P; Kim EY; Wolinsky SM; Malim MH
    J Virol; 2013 Feb; 87(3):1508-17. PubMed ID: 23152537
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Extensive editing of both hepatitis B virus DNA strands by APOBEC3 cytidine deaminases in vitro and in vivo.
    Suspène R; Guétard D; Henry M; Sommer P; Wain-Hobson S; Vartanian JP
    Proc Natl Acad Sci U S A; 2005 Jun; 102(23):8321-6. PubMed ID: 15919829
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome.
    Yu Q; König R; Pillai S; Chiles K; Kearney M; Palmer S; Richman D; Coffin JM; Landau NR
    Nat Struct Mol Biol; 2004 May; 11(5):435-42. PubMed ID: 15098018
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oligomerization transforms human APOBEC3G from an efficient enzyme to a slowly dissociating nucleic acid-binding protein.
    Chaurasiya KR; McCauley MJ; Wang W; Qualley DF; Wu T; Kitamura S; Geertsema H; Chan DS; Hertz A; Iwatani Y; Levin JG; Musier-Forsyth K; Rouzina I; Williams MC
    Nat Chem; 2014 Jan; 6(1):28-33. PubMed ID: 24345943
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dimerization regulates both deaminase-dependent and deaminase-independent HIV-1 restriction by APOBEC3G.
    Morse M; Huo R; Feng Y; Rouzina I; Chelico L; Williams MC
    Nat Commun; 2017 Sep; 8(1):597. PubMed ID: 28928403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.